Linked Life Data

8316339

Source:http://linkedlifedata.com/resource/pubmed/id/8316339

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1993-7-26
pubmed:abstractText
The present study concerns the controversial subject of rheumatoid arthritis (RA) therapy and particularly use of orally administered gold salts (auric triethylphosphine-Auranofin). It contains the results of a study conducted on 10 patients affected with RA who were treated with auric triethylphosphine associated with conventional therapy for a period varying from 4 to 8 years. The efficacy of this therapy in these patients was comparable to that observed in a survey of other studies. The authors conclude that there are advantages offered to RA patients utilizing chrysotherapy and particularly Auranofin can be administered for an extended period without the development of collateral effects in other organs or systems.
pubmed:language
ita
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0026-4806
pubmed:author
pubmed:issnType
Print
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
219-25
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
[Long-term therapy with gold salts in rheumatoid arthritis. Review of the literature and personal contribution].
pubmed:affiliation
Istituto di Patologia Speciale Medica e Metodologia Clinica, Università degli Studi di Bologna.
pubmed:publicationType
Journal Article, English Abstract, Review